Received May 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 3 | 945664 | IM / RA |
Patient did not report an adverse event- patient had already received both doses of a 2 dose series and received an unneeded third dose on 04/05/2025.